General description
LOK (lymphocyte-oriented kinase) belongs to the Ste20 (sterile 20) family of serine/threonine kinases. It is expressed in lymphocytes, brain, colon, thymus, kidney, liver, small intestine and lung. LOK is commonly referred to as STK10 (serine/threonine protein kinase 10).
Biochem/physiol Actions
Mutations in LOK (lymphocyte-oriented kinase) are linked with the anti-apoptotic effects leading to carcinogenesis. It functions as an ERM (ezrin-radixin-moesin) kinase and thereby regulates cytoskeletal organization and lymphocyte migration. It can phosphorylate PLK1 (polo-like kinase 1).
Physical form
Supplied in 50 mM Tris-HCl, pH 7.5, with 150 mM NaCl, 0.2 5mM DTT, 0.1 mM EGTA, 0.1 mM EDTA, 0.1 mM PMSF, and 25% glycerol.
Legal Information
PRECISIO is a registered trademark of Merck KGaA, Darmstadt, Germany
| recombinant | expressed in baculovirus infected Sf9 cells |
| Quality Level | 100 |
| product line | PRECISIO® Kinase |
| assay | ≥70% (SDS-PAGE) |
| form | buffered aqueous glycerol solution |
| specific activity | 2-4 nmol/min·mg |
| mol wt | ~65 kDa |
| UniProt accession no. | O94804 |
| shipped in | dry ice |
| storage temp. | −70°C |
| Gene Information | human ... STK10(6793) |
